A diet food vendor scores by blowing up its business model

Lesson: Eliminate the middleman

EMAIL  |   PRINT  |   SHARE  |   RSS
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)

With a push from Medifast CEO Mike McDevitt's marketing plan, the company serves a new client base.
Which FSB 100 company's products and services do you use most often?
  • The Knot
  • Nathan's Famous
  • Jones Soda
  • LivePerson
  • Bankrate
The richest executives The richest executives The richest executives
These FSB 100 insiders each own $15 million or more in stock and options.

(Fortune Small Business) -- Like a dieter stuck at a demoralizing plateau, Medifast (MED) (No. 47 on this year's FSB 100 list) could have given up.

During the 1980s the Owings Mills, Md., company sold weight-loss products and nutrition bars through a network of health-care professionals who prescribed them to the clinically obese. But in the mid-1990s health insurers stopped covering many diet-food products, including Medifast's. Revenues sank from $14.4 million in 1997 to $6 million the next year. CEO Brad MacDonald cut his staff from 200 to 11, and sales stagnated for the next five years as he fended off bankruptcy.

MacDonald knew Medifast had to rethink its business model. He decided that shaping up the firm would require a different distribution method: selling directly to consumers, not physicians. Medifast took the leap, investing in a call center to handle customer service and adding new e-commerce functionality to its Web site. As a result, after falling to a low of $3.9 million in 2000, sales climbed to $5 million in 2001.

Around that time, Medifast caught the eye of Mike McDevitt, a young private equity analyst at the Blackstone Group in New York City. Despite Medifast's so-so revenues, McDevitt, 30, sensed growth potential. He contacted MacDonald, interviewed for a position as controller, and landed the job.

McDevitt liked MacDonald's direct-sales strategy. But he knew that Medifast had to beef up its marketing to make the new model work. So he poured funds into online and print direct-response ads. The firm also started "Take Shape for Life," an Avon (AVP, Fortune 500)-style multilevel marketing program that allows customers to earn commissions as vendors. Take Shape for Life brought in revenues of $15 million in 2003, its first year. By 2007, the firm's overall sales had shot up to $84 million.

Medifast soon faced a slew of new challenges. The $40 billion weight-loss industry has always been glutted with small players, most of which wind up getting crushed by heavyweights such as Jenny Craig and Nestlé's. But the competition has grown more intense in recent years. Medifast's rivals, including LA Weight Loss and NutriSystem (NTRI), have bulked up their marketing spending as national obesity rates - which are still high - leveled off.

In early 2007, Barron's magazine reported that MacDonald had adopted a pseudonym to tout his firm on Yahoo (YHOO, Fortune 500) Finance message boards - and that he had instantly handed the CEO title to McDevitt when caught. Medifast responded that the succession plan for MacDonald had been laid out in the previous year's 10-Q. Barron's also asserted that an efficacy study on Medifast products, which the firm touted in its ads, had been rejected by the peer-reviewed medical journal Diabetes Care. Dr. Lawrence Cheskin, the author of the study, acknowledges that Diabetes Care declined to publish his work but points out that the study was later published by The Diabetes Educator, which is also peer-reviewed.

Between the competition and the bad press, Medifast took a financial hit. Profits dipped slightly last year, despite a 13% revenue jump. The firm faced delisting by the New York Stock Exchange in December 2007, when its market capitalization fell to a low of $40 million. Medifast's market cap is now at $80 million, which satisfies the exchange's listing requirement of $75 million.

McDevitt, who became president in 2005 and CEO in 2007, blames Medifast's woes on heavy investments in infrastructure and marketing. Medifast launched a network of franchised weight-control centers last December and plans to open 25 locations by 2009. McDevitt also upped ad spending, from $14 million in 2006 to $20 million the next year.

The company's expansion marks another necessary evolution, says Scott Van Winkle, a research analyst with Canaccord Adams in Boston (neither Van Winkle nor his firm invest in or advise Medifast).

"The multichannel approach is the best way for them to grow and differentiate themselves," he says.

After sinking last year, Medifast's stock has risen slowly since March. First-quarter revenues are up 25% over the same period last year, putting the firm on track for annual 2008 sales of more than $100 million. Van Winkle predicts that Medifast's profits will climb within three years.

That wouldn't be surprising for a firm with Medifast's rebounding skills. To top of page

To write a note to the editor about this article, click here.

Find Business Answers
Ask a Question

QMy dream is to launch my own business someday. Now that it's time to choose a major, I'm debating if I should major in entrepreneurial studies or major in engineering to acquire a set of skills first. Is majoring in entrepreneurship a good choice? More
Get Answer
- Spate, Orange, Calif.
10 of the most luxurious airline amenity kits When it comes to in-flight pampering, the amenity kits offered by these 10 airlines are the ultimate in luxury More
7 startups that want to improve your mental health From a text therapy platform to apps that push you reminders to breathe, these self-care startups offer help on a daily basis or in times of need. More
5 radical technologies that will change how you get to work From Uber's flying cars to the Hyperloop, these are some of the neatest transportation concepts in the works today. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.